Published

Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action".

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Frontiers in psychiatry
Date: 2024-01-01
Source: PubMed
DOI: 10.3389/fpsyt.2024.1320780
PubMed: 38983371

Authors

Bornemann J Close JB Ahmad K Barba T Godfrey K Macdonald L Erritzoe D Nutt D Carhart-Harris R

Watch author

Derived topics and classifications

psilocybin Chronic Pain Neuroplasticity Brain Imaging Mechanism of Action Biomarkers Aging Randomized Controlled Trial Observational Study Randomized Controlled Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action".2024-01-01

Related papers

An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in LifeClinicalTrials.gov · 2026-08-17 Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-08-12 Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-08-07 Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older AdultsClinicalTrials.gov · 2025-10-21 Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-05-01 The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive DisorderClinicalTrials.gov · 2026-08-13 Psilocybin-Assisted Therapy for Prolonged GriefClinicalTrials.gov · 2026-06-23 Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-samplingClinicalTrials.gov · 2026-06-05